Why the study?
What are the risk factors for bleeding among cancer patients treated with anticoagulation?
What are the risk factors for bleeding among cancer patients treated with anticoagulation?
Gastrointestinal malignancies, metastatic disease, chronic kidney disease, and thrombocytopenia are key risk factors for bleeding in cancer patients receiving anticoagulation.
Answers are grounded in this paper and cite their sources.
May warrant closer monitoring in these cancer subgroups on anticoagulation; leaves open tailored strategies pending prospective validation.
/L. Bleeding incidence was higher in cancer patients regardless of the anticoagulant used. Patients with gastrointestinal malignancies had a higher incidence of bleeding compared to other tumors across all anticoagulants. Other factors associated with increased risk of bleeding included metastatic disease, chronic kidney disease, and thrombocytopenia.
No takes yet. Share an insight, caveat, or question.
Angelini et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: